These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 39408311)

  • 1. Effect of Obesity and Metabolic Health Status on Metabolic-Associated Steatotic Liver Disease among Renal Transplant Recipients Using Hepatic Steatosis Index.
    Lin IH; Yu YP; Duong TV; Nien SW; Tseng IH; Wu YM; Chiang YJ; Chiang CY; Chiu CH; Wang MH; Yang NC; Wu TH; Wong TC
    Nutrients; 2024 Oct; 16(19):. PubMed ID: 39408311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolically healthy obese subjects are at risk of fatty liver but not of pre-clinical atherosclerosis.
    Sung KC; Cha SC; Sung JW; So MS; Byrne CD
    Nutr Metab Cardiovasc Dis; 2014 Mar; 24(3):256-62. PubMed ID: 24361070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Association between Cardio-metabolic and hepatic indices and anthropometric measures with metabolically obesity phenotypes: a cross-sectional study from the Hoveyzeh Cohort Study.
    Zakerkish M; Hoseinian A; Alipour M; Payami SP
    BMC Endocr Disord; 2023 May; 23(1):122. PubMed ID: 37246210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Obesity is more closely related with hepatic steatosis and fibrosis measured by transient elastography than metabolic health status.
    Huh JH; Kim KJ; Kim SU; Han SH; Han KH; Cha BS; Chung CH; Lee BW
    Metabolism; 2017 Jan; 66():23-31. PubMed ID: 27923446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of metabolically healthy obesity on the risk of incident gastric cancer: a population-based cohort study.
    Hashimoto Y; Hamaguchi M; Obora A; Kojima T; Fukui M
    BMC Endocr Disord; 2020 Jan; 20(1):11. PubMed ID: 31959179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between Obese Phenotype and Mildly Reduced eGFR among the General Population from Rural Northeast China.
    Yu S; Yang H; Guo X; Zheng L; Sun Y
    Int J Environ Res Public Health; 2016 May; 13(6):. PubMed ID: 27240390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver enzymes and vitamin D levels in metabolically healthy but obese individuals: Korean National Health and Nutrition Examination Survey.
    Hong HC; Lee JS; Choi HY; Yang SJ; Yoo HJ; Seo JA; Kim SG; Kim NH; Baik SH; Choi DS; Choi KM
    Metabolism; 2013 Sep; 62(9):1305-12. PubMed ID: 23643404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Weight-adjusted waist index is positively and linearly associated with all-cause and cardiovascular mortality in metabolic dysfunction-associated steatotic liver disease: findings from NHANES 1999-2018.
    Liu W; Yang X; Zhan T; Huang M; Tian X; Tian X; Huang X
    Front Endocrinol (Lausanne); 2024; 15():1457869. PubMed ID: 39403588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in obese metabolic phenotypes over time and risk of incident chronic kidney disease.
    Nam KH; Yun HR; Joo YS; Kim J; Lee S; Lee C; Park KS; Park JT; Chang TI; Kang EW; Yoo TH; Kang SW; Han SH
    Diabetes Obes Metab; 2018 Dec; 20(12):2778-2791. PubMed ID: 29971899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strong association between metabolically-abnormal obesity and gallstone disease in adults under 50 years.
    Su PY; Hsu YC; Cheng YF; Kor CT; Su WW
    BMC Gastroenterol; 2019 Jul; 19(1):117. PubMed ID: 31272395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic unhealthiness is an important predictor for the development of advanced colorectal neoplasia.
    Kim TJ; Kim ER; Hong SN; Kim YH; Chang DK; Ji J; Kim JE; Kim HS; Kim K; Son HJ
    Sci Rep; 2017 Aug; 7(1):9011. PubMed ID: 28827625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-Term Prognosis of Acute Myocardial Infarction Associated With Metabolic Health and Obesity Status.
    Chew NWS; Kong G; Venisha S; Chin YH; Ng CH; Muthiah M; Khoo CM; Chai P; Kong W; Poh KK; Foo R; Yeo TC; Chan MY; Loh PH
    Endocr Pract; 2022 Aug; 28(8):802-810. PubMed ID: 35654337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fatty liver index is a risk determinant of incident type 2 diabetes in a metabolically healthy population with obesity.
    Jung CH; Kang YM; Jang JE; Hwang JY; Kim EH; Park JY; Kim HK; Lee WJ
    Obesity (Silver Spring); 2016 Jun; 24(6):1373-9. PubMed ID: 27112320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic abnormalities, but not obesity, contribute to the mildly reduced eGFR in middle-aged and elderly Chinese.
    Wang C; Liang K; Zhang X; Li C; Yang W; Ma Z; Sun Y; Song J; Lin P; Gong L; Wang M; Liu F; Li W; Xiao J; Yan F; Yang J; Wang L; Tian M; Liu J; Zhao R; Hou X; Chen L
    Int Urol Nephrol; 2014 Sep; 46(9):1793-9. PubMed ID: 25099525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic obesity phenotypes: a friend or foe of digestive polyps?-An observational study based on National Inpatient Database.
    Cheng Y; Han J; Li Q; Shi Y; Zhong F; Wu Y; Wang Z; Yuan Z; Fan X; Zhao J
    Metabolism; 2022 Jul; 132():155201. PubMed ID: 35427603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood glucose control and metabolic dysfunction-associated steatotic liver disease in people with type 1 diabetes.
    Della Pepa G; Lupoli R; Masulli M; Boccia R; De Angelis R; Gianfrancesco S; Piccolo R; Rainone C; Rivellese AA; Annuzzi G; Bozzetto L
    J Endocrinol Invest; 2024 Sep; 47(9):2371-2378. PubMed ID: 38498227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolically healthy obesity and risk of non-alcoholic fatty liver disease severity independent of visceral fat.
    Chen TP; Lin WY; Chiang CH; Shen TH; Huang KC; Yang KC
    J Gastroenterol Hepatol; 2021 Oct; 36(10):2903-2910. PubMed ID: 33973273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal changes in Mediterranean diet and transition between different obesity phenotypes.
    Konieczna J; Yañez A; Moñino M; Babio N; Toledo E; Martínez-González MA; Sorlí JV; Salas-Salvadó J; Estruch R; Ros E; Alonso-Gómez A; Schröder H; Lapetra J; Serra-Majem L; Pintó X; Gutiérrez-Bedmar M; Díaz-López A; González JI; Fitó M; Forga L; Fiol M; Romaguera D
    Clin Nutr; 2020 Mar; 39(3):966-975. PubMed ID: 31053509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gender Differences in Liver Steatosis and Fibrosis in Overweight and Obese Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease before and after 8 Weeks of Very Low-Calorie Ketogenic Diet.
    Rinaldi R; De Nucci S; Donghia R; Donvito R; Cerabino N; Di Chito M; Penza A; Mongelli FP; Shahini E; Zappimbulso M; Pesole PL; Coletta S; Triggiani V; Cozzolongo R; Giannelli G; De Pergola G
    Nutrients; 2024 May; 16(10):. PubMed ID: 38794646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammatory Bowel Disease Is an Independent Risk Factor for Metabolic Dysfunction-Associated Steatotic Liver Disease in Lean Individuals.
    Martínez-Domínguez SJ; García-Mateo S; Gargallo-Puyuelo CJ; Gallego-Llera B; Callau P; Mendi C; Arroyo-Villarino MT; Simón-Marco MÁ; Ampuero J; Gomollón F
    Inflamm Bowel Dis; 2024 Aug; 30(8):1274-1283. PubMed ID: 37607330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.